Ara
Toplam kayıt 60, listelenen: 1-10
Classification of Kounis syndrome
(Elsevier Ireland Ltd, 2017)
[No abstract available]
Rationale, Design, and Methodology of the APOLLON trial: A comPrehensive, ObservationaL registry of heart faiLure with mid-range and preserved ejectiON fraction
(Turkish Soc Cardiology, 2018)
Objective: Although almost half of chronic heart failure (HF) patients have mid-range (HFmrEF) and preserved left-ventricular ejection fraction (HFpEF), no studies have been carried out with these patients in our country. ...
Biventricular non-compaction cardiomyopathy with pulmonary stenosis, interatrial septal aneurysm, atrial septal defect, bradycardia, and mental retardation in a single case: A case report
(Turkish Soc Cardiology, 2018)
[No abstract available]
Design and rationale for the ASSOS study: Appropriateness of aspirin use in medical outpatients a multicenter and observational study
(Turkish Soc Cardiology, 2018)
Objective: The aim of this study was to describe the current status of aspirin use and the demographic characteristics of patients on aspirin for primary and secondary prevention of cardiovascular diseases. Methods: The ...
Electroconvulsive Therapy and Anticoagulation
(Elsevier Science Inc, 2019)
[No abstract available]
GEMIFLOXACIN-INDUCED ALLERGIC MYOCARDIAL INFARCTION: A CASE REPORT
(Elsevier Science Inc, 2019)
Background: Gemifloxacin given once daily for 5-7 days has been shown to be non-inferior to, or in some instances superior to, comparator agents for the treatment of common lower respiratory tract infections. Gemifloxacin ...
LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY
(Elsevier Ireland Ltd, 2019)
[No abstract available]
Does heart failure with mid-range ejection fraction resemble heart failure with preserved ejection fraction?
(Springer, 2020)
[No abstract available]
Management of LDL-cholesterol levels in patients with Diabetes Mellitus in Cardiology Practice: Real life evidence of Under-treatment from the EPHESUS registry
(Wiley, 2021)
Background and aims
Effective treatment of high low‐density lipoprotein cholesterol (LDL‐C) levels has been shown to improve cardiovascular outcomes of patients with diabetes mellitus (DM). Herein, we aimed to provide ...
Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19
(Wiley, 2021)
Hydroxychloroquine (HCQ) and azithromycin (AZM) are widely used in off‐label treatment of novel coronavirus disease (COVID‐19). However, cardiac safety of these drugs is still controversial in COVID‐19. Therefore, we aimed ...